National inpatient hospital sepsis, SIRS, Immune Response – Concepts, Diagnostics and Therapy PDF: the most expensive conditions by payer, 2011. Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. Gaieski DF, Edwards JM, Kallan MJ, Carr BG.
Författare: Axel Nierhaus.
Sepsis and septic shock and the delayed multi-organ dysfunction syndrome (MODS) continue to be the major determinants for adverse outcome in critically ill patients, even though substantial advances in the field of supportive care could be identified recently. However, MODS still remains a serious threat. There is convincing evidence that MODS is essentially the clinical expression of profoundly dysregulated pathways of the innate and adaptive immune system, ultimately leading to organ failure and death.
This book contains the major part of the program of the Fourth International Symposium on “Sepsis, SIRS, Immune Response”, held in Hamburg in June 2005.
Once again, an international and multidisciplinary group of experts was gathered to discuss and review recent progress in the field of critical care with special emphasis on diagnosis, prevention and therapy of pathological alterations of the immune system in inflammation and sepsis.
Benchmarking the incidence and mortality of severe sepsis in the United States. Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis care—reasons for caution. International Forum of Acute Care Trialists. Assessment of global incidence and mortality of hospital-treated sepsis: current estimates and limitations.
Am J Respir Crit Care Med. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. Bone RC, Balk RA, Cerra FB, et al.
Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Vincent J-L, Opal SM, Marshall JC, Tracey KJ. Seymour CW, Liu V, Iwashyna TJ, et al Assessment of clinical criteria for sepsis. Shankar-Hari M, Phillips G, Levy ML, et al Assessment of definition and clinical criteria for septic shock.
Angus DC, van der Poll T. Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.